14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
INTC vs PFE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Pfizer Inc. (PFE) is the stronger overall head-to-head candidate over Intel Corp (INTC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). INTC carries a Unified Composite Score of 56.3/100 (HOLD) at $51.28 (28.6x Forward P/E, 10.3% operating margin), whereas PFE carries 49.4/100 (HOLD) at $27.40 (9.3x Forward P/E, 29.1% operating margin).
Composite vs. Pillar Nuance: While INTC currently prints a higher short-term Unified Composite Score (56.3/100 HOLD vs. PFE 49.4/100 HOLD), PFE captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (29.1% vs. 10.3% operating margin) and revenue trajectory (-0.4% vs. +20.9% YoY).
Technical & Structure Timing Caution: INTC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile PFE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Integrated x86 CPU Designer & Domestic Foundry Operator
Operates dual client/server x86 processor franchises alongside domestic leading-edge wafer fabrication and advanced packaging investments.
OpEx & R&D Reinvestment29.9% of Rev ($17.9B)
90D Engineering Disclosures5 Published · Neuromorphic Computing
Mapped Supply-Chain Ecosystem (18 partners):
ASML HoldingTaiwan Semiconductor Manufacturing CompanyApplied MaterialsLam Research
Active 90D Technical Topics:
Edge AI / Inference ChipsKV-Cache / Attention Memory CompressionLow-Precision Inference (FP4/FP8)World Models / Embodied AI
PFE Moat ProfileScale & Operating Efficiency Moat
Drug Manufacturers - General Operator
Competes within the Drug Manufacturers - General value chain with $157.0B market capitalization and 29.1% operating margin.
OpEx & R&D Reinvestment45.8% of Rev ($29.1B)
90D Engineering Disclosures0 Published
Investor FAQ INTC vs PFE Key Questions & Quantitative Answers
As of Nov 20, 2026, Pfizer Inc. (PFE) is the stronger overall head-to-head candidate over Intel Corp (INTC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). INTC carries a Unified Composite Score of 56.3/100 (HOLD) at $51.28 (28.6x Forward P/E, 10.3% operating margin), whereas PFE carries 49.4/100 (HOLD) at $27.40 (9.3x Forward P/E, 29.1% operating margin). Composite vs. Pillar Nuance: While INTC currently prints a higher short-term Unified Composite Score (56.3/100 HOLD vs. PFE 49.4/100 HOLD), PFE captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (29.1% vs. 10.3% operating margin) and revenue trajectory (-0.4% vs. +20.9% YoY). Technical & Structure Timing Caution: INTC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile PFE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
INTC leads the Growth & Scale pillar: INTC posts +20.9% YoY revenue growth and -32.7% YoY earnings growth on $59.9B TTM revenue (40.2% gross margin, 10.3% operating margin), compared with PFE at -0.4% YoY revenue growth and -9.7% YoY earnings growth on $63.6B TTM revenue (74.9% gross margin, 29.1% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), INTC cumulative revenue shifted -25.4% while PFE shifted +53.3%. In operating R&D and SG&A reinvestment, INTC deploys 29.9% of Rev ($17.9B) (5 90-day corporate R&D disclosures) versus 45.8% of Rev ($29.1B) (0 disclosures) for PFE.
PFE screens cheaper on headline valuation multiples. INTC trades at 28.6x Forward P/E, 32.4x Trailing P/E, 0.50x PEG, and 5.4x EV/Revenue (6.3% FCF margin), whereas PFE trades at 9.3x Forward P/E, 39.3x Trailing P/E, 8.56x PEG, and 3.4x EV/Revenue (18.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against INTC (-9.6% ROE) versus PFE (4.5% ROE) capital efficiency.
In options market volatility and institutional positioning, INTC carries 133.5% implied volatility (64th %ile, Elevated (60th–80th %ile)), a 1.23x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.28β · 122% Vol realized risk). By comparison, PFE carries 48.1% implied volatility (58th %ile, Balanced (25th–60th %ile)), a 0.62x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.18β · 22% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.